- Home
- GHG vs TNXP Comparison
GHG vs TNXP Comparison
Compare GHG & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHG
- TNXP
- Stock Information
- Founded
- GHG 2004
- TNXP 2007
- Country
- GHG China
- TNXP United States
- Employees
- GHG N/A
- TNXP N/A
- Industry
- GHG Hotels/Resorts
- TNXP Biotechnology: Pharmaceutical Preparations
- Sector
- GHG Consumer Discretionary
- TNXP Health Care
- Exchange
- GHG Nasdaq
- TNXP Nasdaq
- Market Cap
- GHG 202.0M
- TNXP 207.5M
- IPO Year
- GHG 2018
- TNXP N/A
- Fundamental
- Price
- GHG $2.00
- TNXP $33.33
- Analyst Decision
- GHG
- TNXP Strong Buy
- Analyst Count
- GHG 0
- TNXP 2
- Target Price
- GHG N/A
- TNXP $585.00
- AVG Volume (30 Days)
- GHG 14.7K
- TNXP 1.1M
- Earning Date
- GHG 08-14-2025
- TNXP 08-15-2025
- Dividend Yield
- GHG 4.15%
- TNXP N/A
- EPS Growth
- GHG N/A
- TNXP N/A
- EPS
- GHG 0.15
- TNXP N/A
- Revenue
- GHG $184,055,595.00
- TNXP $10,041,000.00
- Revenue This Year
- GHG $19.02
- TNXP $11.66
- Revenue Next Year
- GHG $8.26
- TNXP $793.18
- P/E Ratio
- GHG $13.74
- TNXP N/A
- Revenue Growth
- GHG N/A
- TNXP N/A
- 52 Week Low
- GHG $1.93
- TNXP $6.76
- 52 Week High
- GHG $3.40
- TNXP $137.25
- Technical
- Relative Strength Index (RSI)
- GHG 47.81
- TNXP 52.50
- Support Level
- GHG $1.93
- TNXP $33.41
- Resistance Level
- GHG $2.15
- TNXP $37.42
- Average True Range (ATR)
- GHG 0.09
- TNXP 3.48
- MACD
- GHG 0.00
- TNXP -1.12
- Stochastic Oscillator
- GHG 44.00
- TNXP 33.66
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.